Patent Results

58 Results for: citation_id:11970878
Make Note

Compositions And Methods For Inhibition Of The Jak Pathway

  • Published: Feb 17, 2009
  • Family: 41
  • Cited scholarly works: 69
  • Cited by: 77
  • Cites: 100
  • Additional Info: Cited Works Full text Published
  • Owner: Rigel Pharmaceuticals Inc
  • Applicant: Rigel Pharmaceuticals Inc

Prodrugs Of 2,4-pyrimidinediamine Compounds And Their Uses

  • Published: May 26, 2009
  • Family: 51
  • Cited scholarly works: 100
  • Cited by: 34
  • Cites: 99
  • Additional Info: Cited Works Full text Published
  • Owner: Rigel Pharmaceuticals Inc
  • Applicant: Rigel Pharmaceuticals Inc

Prodrugs Of 2,4 Pyrimidinediamine Compounds And Their Uses

  • Published: Jul 21, 2009
  • Family: 51
  • Cited scholarly works: 99
  • Cited by: 38
  • Cites: 99
  • Additional Info: Cited Works Full text Published
  • Owner: Rigel Pharmaceuticals Inc
  • Applicant: Rigel Pharmaceuticals Inc

Inhibitors Of Syk Protein Kinase

  • Published: Nov 12, 2009
  • Family: 22
  • Cited scholarly works: 69
  • Cited by: 103
  • Cites: 20
  • Additional Info: Cited Works Full text Published
  • Applicant: Portola Pharm Inc, Jia Zhaozhong J, Venkataramani Chandrasekar, Huang Wolin, Mehrotra Mukund, Song Yonghong, Xu Qing, Bauer Shawn M, Pandey Anjali

Methods Of Treating Or Preventing Autoimmune Diseases With 2,4-pyrimidinediamine Compounds

  • Published: Dec 9, 2009
  • Family: 5
  • Cited scholarly works: 37
  • Cited by: 0
  • Cites: 28
  • Additional Info: Cited Works Published
  • Applicant: Rigel Pharmaceuticals Inc

2,4-pyrimidinediamine Compounds For Treating Or Preventing Autoimmune Diseases

  • Published: Feb 9, 2010
  • Family: 18
  • Cited scholarly works: 42
  • Cited by: 15
  • Cites: 52
  • Additional Info: Cited Works Full text Published
  • Owner: Rigel Pharmaceuticals Inc
  • Applicant: Rigel Pharmaceuticals Inc

Aminotriazolopyridines And Their Use As Kinase Inhibitors

  • Published: Mar 11, 2010
  • Family: 30
  • Cited scholarly works: 12
  • Cited by: 83
  • Cites: 3
  • Additional Info: Cited Works Full text Published
  • Applicant: Signal Pharm Llc, Bahmanyar Sogole, Bates R J, Blease Kate, Calabrese Andrew Antony, Daniel Thomas Oran, Delgado Mercedes, Elsner Jan, Erdman Paul, Fahr Bruce, Ferguson Gregory, Lee Branden, Nadolny Lisa, Packard Garrick, Papa Patrick, Plantevin-krenitsky Veronique, Riggs Jennifer, Rohane Patricia, Sankar Sabita, Sapienza John, Satoh Yoshitaka, Sloan Victor, Stevens Randall, Tehrani Lida, Tikhe Jayashree, Torres Eduardo, Wallace Andrew, Whitefield Brandon Wade, Zhao Jingjing

Compositions And Methods For Inhibition Of The Jak Pathway

  • Published: Aug 30, 2007
  • Family: 12
  • Cited scholarly works: 68
  • Cited by: 9
  • Cites: 157
  • Additional Info: Cited Works Full text Published
  • Applicant: Rigel Pharmaceuticals Inc, Li Hui, Argade Ankush, Tso Kin, Thota Sambaiah, Carroll David, Sran Arvinder, Cooper Robin, Singh Rajinder, Bhamidipati Somasekhar, Masuda Esteban, Taylor Vanessa

Compositions And Methods For Inhibition Of The Jak Pathway

  • Published: Dec 14, 2006
  • Family: 41
  • Cited scholarly works: 4
  • Cited by: 100
  • Cites: 8
  • Additional Info: Cited Works Full text Published
  • Applicant: Rigel Pharmaceuticals Inc, Li Hui, Thota Sambaiah, Carroll David, Argade Ankush, Tso Kin, Sran Arvinder, Clough Jeffrey, Keim Holger, Bhamidipati Somasekhar, Taylor Vanessa, Cooper Robin, Singh Rajinder, Wong Brian

Prodrugs Of 2,4-pyrimidinediamine Compounds And Their Uses

  • Published: Nov 11, 2008
  • Family: 51
  • Cited scholarly works: 96
  • Cited by: 49
  • Cites: 99
  • Additional Info: Cited Works Full text Published
  • Owner: Rigel Pharmaceuticals Inc
  • Applicant: Rigel Pharmaceuticals Inc

Add Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save Query

Sign in to the Lens